Gene Symbol | Gene ID | Gene Info |
---|---|---|
Myf6
|
ENSMUSG00000035923.3 | myogenic factor 6 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_107493348_107493519 | Myf6 | 1304 | 0.431917 | 0.85 | 1.7e-16 | Click! |
chr10_107493731_107493882 | Myf6 | 931 | 0.561436 | 0.81 | 7.1e-14 | Click! |
chr10_107499841_107499992 | Myf6 | 5179 | 0.205017 | 0.18 | 1.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_126740592_126740784 | 19.94 |
Kcna6 |
potassium voltage-gated channel, shaker-related, subfamily, member 6 |
14 |
0.98 |
chr8_9770576_9770782 | 18.02 |
Gm47312 |
predicted gene, 47312 |
201 |
0.66 |
chr3_134146920_134147071 | 17.48 |
Gm44361 |
predicted gene, 44361 |
113 |
0.96 |
chr9_75625075_75626579 | 15.15 |
Lysmd2 |
LysM, putative peptidoglycan-binding, domain containing 2 |
68 |
0.96 |
chr14_14983885_14984321 | 13.63 |
Nek10 |
NIMA (never in mitosis gene a)- related kinase 10 |
53528 |
0.11 |
chr14_69028957_69029191 | 13.05 |
Stc1 |
stanniocalcin 1 |
164 |
0.85 |
chr18_36197046_36197216 | 11.36 |
Nrg2 |
neuregulin 2 |
101 |
0.97 |
chr16_41532913_41533104 | 11.22 |
Lsamp |
limbic system-associated membrane protein |
29 |
0.99 |
chr14_14350947_14351733 | 11.06 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr7_99267195_99268129 | 10.69 |
Map6 |
microtubule-associated protein 6 |
173 |
0.76 |
chr13_59040994_59041159 | 10.33 |
Gm34245 |
predicted gene, 34245 |
37220 |
0.14 |
chr14_123626303_123627238 | 9.99 |
Nalcn |
sodium leak channel, non-selective |
106 |
0.98 |
chr9_92930513_92930898 | 9.87 |
Gm28054 |
predicted gene 28054 |
34873 |
0.17 |
chr6_6872048_6872218 | 9.82 |
Dlx6os1 |
distal-less homeobox 6, opposite strand 1 |
541 |
0.67 |
chr3_89520552_89520924 | 9.48 |
Kcnn3 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 |
574 |
0.7 |
chr6_77979415_77979709 | 9.42 |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
2 |
0.98 |
chr9_8900765_8902148 | 9.20 |
Pgr |
progesterone receptor |
988 |
0.68 |
chr8_106300816_106300982 | 8.98 |
Gm10629 |
predicted gene 10629 |
17592 |
0.15 |
chr6_37299433_37299820 | 8.59 |
Dgki |
diacylglycerol kinase, iota |
11 |
0.99 |
chr13_15602594_15602999 | 8.17 |
Gm48343 |
predicted gene, 48343 |
47139 |
0.16 |
chr7_79525641_79525821 | 8.10 |
Mir9-3hg |
Mir9-3 host gene |
2119 |
0.16 |
chr18_43687278_43687971 | 7.99 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
1 |
0.98 |
chr10_3863520_3864007 | 7.88 |
Gm16149 |
predicted gene 16149 |
5844 |
0.21 |
chr1_84585391_84585851 | 7.82 |
Dner |
delta/notch-like EGF repeat containing |
38220 |
0.17 |
chr2_23234368_23234740 | 7.80 |
Gm13422 |
predicted gene 13422 |
682 |
0.66 |
chr7_73740150_73741122 | 7.73 |
A830073O21Rik |
RIKEN cDNA A830073O21 gene |
281 |
0.52 |
chr9_40268412_40269319 | 7.71 |
Scn3b |
sodium channel, voltage-gated, type III, beta |
352 |
0.82 |
chr2_48318409_48318876 | 7.62 |
Gm13482 |
predicted gene 13482 |
19734 |
0.23 |
chr11_69800147_69800349 | 7.61 |
Fgf11 |
fibroblast growth factor 11 |
1468 |
0.15 |
chr6_55676658_55677265 | 7.58 |
Neurod6 |
neurogenic differentiation 6 |
4302 |
0.26 |
chr5_148264790_148265134 | 7.43 |
Mtus2 |
microtubule associated tumor suppressor candidate 2 |
255 |
0.94 |
chr1_3671269_3672324 | 7.41 |
Xkr4 |
X-linked Kx blood group related 4 |
298 |
0.89 |
chr4_66403446_66404232 | 7.35 |
Astn2 |
astrotactin 2 |
644 |
0.81 |
chr13_38346067_38346557 | 7.09 |
Bmp6 |
bone morphogenetic protein 6 |
159 |
0.95 |
chr1_51650752_51650944 | 7.05 |
Gm28055 |
predicted gene 28055 |
47052 |
0.14 |
chr7_4119309_4120004 | 7.02 |
Ttyh1 |
tweety family member 1 |
34 |
0.91 |
chr14_47366959_47367257 | 6.99 |
Lgals3 |
lectin, galactose binding, soluble 3 |
643 |
0.58 |
chr12_105453942_105454636 | 6.99 |
D430019H16Rik |
RIKEN cDNA D430019H16 gene |
433 |
0.83 |
chr1_153641449_153641897 | 6.98 |
Rgs8 |
regulator of G-protein signaling 8 |
11352 |
0.15 |
chr4_90437683_90437870 | 6.93 |
Gm12635 |
predicted gene 12635 |
15098 |
0.24 |
chr16_77788297_77788506 | 6.86 |
Gm17333 |
predicted gene, 17333 |
58203 |
0.11 |
chr16_28752897_28753619 | 6.85 |
Fgf12 |
fibroblast growth factor 12 |
190 |
0.97 |
chr12_108333504_108334768 | 6.78 |
Cyp46a1 |
cytochrome P450, family 46, subfamily a, polypeptide 1 |
245 |
0.91 |
chr18_65873034_65873185 | 6.75 |
Grp |
gastrin releasing peptide |
61 |
0.95 |
chr6_82939285_82939948 | 6.72 |
Sema4f |
sema domain, immunoglobulin domain (Ig), TM domain, and short cytoplasmic domain |
71 |
0.94 |
chr4_111414397_111414736 | 6.71 |
Bend5 |
BEN domain containing 5 |
440 |
0.86 |
chr10_125388906_125389759 | 6.66 |
Slc16a7 |
solute carrier family 16 (monocarboxylic acid transporters), member 7 |
36 |
0.95 |
chr14_24617341_24617911 | 6.63 |
4930428N03Rik |
RIKEN cDNA 4930428N03 gene |
58 |
0.64 |
chr5_107497460_107497812 | 6.57 |
Btbd8 |
BTB (POZ) domain containing 8 |
140 |
0.93 |
chr12_27064915_27065316 | 6.45 |
Gm9866 |
predicted gene 9866 |
49880 |
0.18 |
chrX_143518439_143518663 | 6.43 |
Pak3 |
p21 (RAC1) activated kinase 3 |
40 |
0.99 |
chr3_46891172_46891323 | 6.32 |
Mir6379 |
microRNA 6379 |
9535 |
0.31 |
chr15_34824497_34824736 | 6.28 |
Gm48932 |
predicted gene, 48932 |
1813 |
0.39 |
chr1_124045941_124046349 | 6.27 |
Dpp10 |
dipeptidylpeptidase 10 |
586 |
0.86 |
chr13_12312047_12312406 | 6.24 |
Actn2 |
actinin alpha 2 |
28498 |
0.14 |
chr2_105611972_105612254 | 6.20 |
Paupar |
Pax6 upstream antisense RNA |
49230 |
0.11 |
chr10_87492542_87493159 | 6.15 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
810 |
0.64 |
chr9_112207779_112208199 | 6.14 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
9272 |
0.2 |
chr3_62603661_62604074 | 6.12 |
Gpr149 |
G protein-coupled receptor 149 |
1093 |
0.65 |
chr18_67497794_67498327 | 6.11 |
Spire1 |
spire type actin nucleation factor 1 |
331 |
0.86 |
chr10_45311684_45311835 | 6.08 |
Gm47433 |
predicted gene, 47433 |
13488 |
0.14 |
chr10_81364518_81366962 | 6.07 |
4930404N11Rik |
RIKEN cDNA 4930404N11 gene |
50 |
0.91 |
chr12_53247011_53247372 | 5.99 |
Npas3 |
neuronal PAS domain protein 3 |
966 |
0.69 |
chr13_105256983_105257274 | 5.98 |
Rnf180 |
ring finger protein 180 |
13911 |
0.24 |
chr4_23982818_23983489 | 5.97 |
Gm28448 |
predicted gene 28448 |
49199 |
0.19 |
chr18_57259113_57259264 | 5.95 |
Gm50200 |
predicted gene, 50200 |
55952 |
0.1 |
chr1_132739219_132739652 | 5.94 |
Nfasc |
neurofascin |
2322 |
0.3 |
chr12_61526290_61526584 | 5.94 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
2489 |
0.28 |
chr2_6877098_6877407 | 5.92 |
Celf2 |
CUGBP, Elav-like family member 2 |
4655 |
0.22 |
chr14_54912471_54913268 | 5.89 |
Slc22a17 |
solute carrier family 22 (organic cation transporter), member 17 |
21 |
0.93 |
chr1_194623663_194623996 | 5.86 |
Plxna2 |
plexin A2 |
4004 |
0.23 |
chrX_73815081_73815241 | 5.83 |
Gm23615 |
predicted gene, 23615 |
5744 |
0.1 |
chr11_66525728_66526049 | 5.83 |
Shisa6 |
shisa family member 6 |
76 |
0.98 |
chr2_55436835_55437680 | 5.80 |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
92 |
0.98 |
chr9_65724670_65724847 | 5.79 |
Zfp609 |
zinc finger protein 609 |
23614 |
0.15 |
chr10_26695225_26695646 | 5.75 |
Gm48893 |
predicted gene, 48893 |
139 |
0.96 |
chr1_136259884_136260870 | 5.75 |
Gpr25 |
G protein-coupled receptor 25 |
496 |
0.56 |
chr9_40241243_40241790 | 5.73 |
Scn3b |
sodium channel, voltage-gated, type III, beta |
27701 |
0.11 |
chrX_100767602_100767791 | 5.72 |
Dlg3 |
discs large MAGUK scaffold protein 3 |
26 |
0.97 |
chr15_64060029_64060819 | 5.71 |
Fam49b |
family with sequence similarity 49, member B |
4 |
0.98 |
chr16_19759999_19760363 | 5.70 |
B3gnt5 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
27 |
0.98 |
chr1_119049949_119050658 | 5.68 |
Gli2 |
GLI-Kruppel family member GLI2 |
3036 |
0.28 |
chr9_119510823_119511314 | 5.68 |
Scn5a |
sodium channel, voltage-gated, type V, alpha |
51610 |
0.1 |
chr10_67549265_67549730 | 5.67 |
Ado |
2-aminoethanethiol (cysteamine) dioxygenase |
429 |
0.76 |
chr9_41665518_41665690 | 5.63 |
Gm48784 |
predicted gene, 48784 |
9450 |
0.14 |
chr2_142334534_142334733 | 5.56 |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
158026 |
0.04 |
chr10_57784462_57784659 | 5.53 |
Fabp7 |
fatty acid binding protein 7, brain |
321 |
0.86 |
chr2_30718241_30719386 | 5.53 |
Gm14488 |
predicted gene 14488 |
1244 |
0.36 |
chrX_21361456_21361640 | 5.50 |
Gm5124 |
predicted pseudogene 5124 |
608 |
0.76 |
chr1_128595642_128595830 | 5.49 |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
3443 |
0.27 |
chr12_105336106_105336602 | 5.46 |
Tunar |
Tcl1 upstream neural differentiation associated RNA |
240 |
0.93 |
chr6_37038602_37038761 | 5.46 |
Dgki |
diacylglycerol kinase, iota |
7653 |
0.28 |
chr8_10053567_10053726 | 5.44 |
Gm44788 |
predicted gene 44788 |
11408 |
0.17 |
chr1_132200708_132201234 | 5.44 |
Lemd1 |
LEM domain containing 1 |
8 |
0.96 |
chr19_36553934_36555231 | 5.42 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
57 |
0.98 |
chr4_45184399_45185347 | 5.40 |
Frmpd1 |
FERM and PDZ domain containing 1 |
2 |
0.98 |
chr18_22850488_22850657 | 5.38 |
Nol4 |
nucleolar protein 4 |
182 |
0.98 |
chr9_102211189_102211590 | 5.36 |
Gm37945 |
predicted gene, 37945 |
38651 |
0.13 |
chr4_119460677_119461253 | 5.34 |
Zmynd12 |
zinc finger, MYND domain containing 12 |
16245 |
0.1 |
chr5_150906447_150906658 | 5.33 |
Gm43298 |
predicted gene 43298 |
23910 |
0.17 |
chr13_64161300_64162707 | 5.33 |
Habp4 |
hyaluronic acid binding protein 4 |
134 |
0.93 |
chr4_103619376_103619527 | 5.29 |
Dab1 |
disabled 1 |
92 |
0.97 |
chrX_137806587_137806760 | 5.27 |
Il1rapl2 |
interleukin 1 receptor accessory protein-like 2 |
154953 |
0.04 |
chr5_26991582_26992107 | 5.27 |
Gm16057 |
predicted gene 16057 |
15777 |
0.25 |
chr2_101172759_101173110 | 5.27 |
Gm20693 |
predicted gene 20693 |
397690 |
0.01 |
chr5_111220876_111221370 | 5.26 |
Ttc28 |
tetratricopeptide repeat domain 28 |
4335 |
0.22 |
chr18_56287782_56287935 | 5.26 |
Gm50385 |
predicted gene, 50385 |
3006 |
0.31 |
chr7_79578006_79578675 | 5.23 |
Gm45168 |
predicted gene 45168 |
728 |
0.49 |
chr5_37162967_37163149 | 5.22 |
Gm1043 |
predicted gene 1043 |
209 |
0.94 |
chr1_104746793_104747206 | 5.21 |
Cdh20 |
cadherin 20 |
21530 |
0.2 |
chr18_5978462_5978815 | 5.21 |
Gm34804 |
predicted gene, 34804 |
33455 |
0.17 |
chr9_52679712_52680046 | 5.21 |
Gm1715 |
predicted gene 1715 |
16 |
0.58 |
chr18_60065037_60065286 | 5.19 |
Gm23576 |
predicted gene, 23576 |
109156 |
0.06 |
chr1_33042557_33042708 | 5.18 |
Gm28624 |
predicted gene 28624 |
12342 |
0.18 |
chr8_122284023_122284944 | 5.18 |
Zfpm1 |
zinc finger protein, multitype 1 |
2342 |
0.24 |
chr6_115126272_115126705 | 5.17 |
Gm17733 |
predicted gene, 17733 |
8347 |
0.14 |
chr15_72657768_72657941 | 5.14 |
Gm28020 |
predicted gene, 28020 |
63533 |
0.11 |
chr1_180332122_180332723 | 5.13 |
Itpkb |
inositol 1,4,5-trisphosphate 3-kinase B |
1444 |
0.28 |
chr4_54653168_54653411 | 5.13 |
Gm12480 |
predicted gene 12480 |
1386 |
0.37 |
chr5_112237414_112237869 | 5.13 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
8246 |
0.12 |
chr13_93771513_93772266 | 5.12 |
Arsb |
arylsulfatase B |
193 |
0.63 |
chr11_32057406_32057740 | 5.12 |
Gm12108 |
predicted gene 12108 |
43655 |
0.13 |
chr15_99807879_99808072 | 5.11 |
Gm4468 |
predicted gene 4468 |
2607 |
0.13 |
chr9_61862103_61862486 | 5.11 |
Gm19208 |
predicted gene, 19208 |
10590 |
0.22 |
chr12_3364588_3366025 | 5.11 |
Kif3c |
kinesin family member 3C |
116 |
0.94 |
chr16_37584223_37584651 | 5.07 |
Hgd |
homogentisate 1, 2-dioxygenase |
4155 |
0.17 |
chr6_136241845_136241996 | 5.06 |
Gm26105 |
predicted gene, 26105 |
39307 |
0.15 |
chr7_89628064_89628348 | 5.06 |
Me3 |
malic enzyme 3, NADP(+)-dependent, mitochondrial |
4186 |
0.19 |
chr13_64903638_64903908 | 5.05 |
Cntnap3 |
contactin associated protein-like 3 |
182 |
0.93 |
chr16_11087057_11087237 | 5.05 |
Txndc11 |
thioredoxin domain containing 11 |
205 |
0.89 |
chr19_49299443_49299603 | 5.04 |
Gm50442 |
predicted gene, 50442 |
208850 |
0.02 |
chr3_5347552_5347820 | 5.04 |
Zfhx4 |
zinc finger homeodomain 4 |
106014 |
0.07 |
chr12_116709666_116709817 | 5.04 |
Gm17807 |
predicted gene, 17807 |
112488 |
0.06 |
chrX_73880149_73880806 | 5.03 |
L1cam |
L1 cell adhesion molecule |
318 |
0.8 |
chr11_111296488_111296797 | 5.03 |
Gm11675 |
predicted gene 11675 |
20542 |
0.29 |
chr6_100438555_100439012 | 5.03 |
Gm23234 |
predicted gene, 23234 |
56031 |
0.11 |
chr7_57591199_57591501 | 5.03 |
Gabrb3 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
177 |
0.96 |
chr10_22140790_22140967 | 5.03 |
E030030I06Rik |
RIKEN cDNA E030030I06 gene |
7732 |
0.1 |
chr3_109782232_109782939 | 4.97 |
Ntng1 |
netrin G1 |
50674 |
0.16 |
chr15_4375378_4375720 | 4.95 |
Plcxd3 |
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
45 |
0.99 |
chr3_45380711_45381562 | 4.95 |
Pcdh10 |
protocadherin 10 |
1497 |
0.34 |
chr4_134430506_134430992 | 4.94 |
1700021N21Rik |
RIKEN cDNA 1700021N21 gene |
19422 |
0.1 |
chr5_44696475_44696626 | 4.91 |
Gm3364 |
predicted gene 3364 |
10340 |
0.13 |
chr7_44382547_44382866 | 4.91 |
Syt3 |
synaptotagmin III |
1396 |
0.19 |
chr15_39076756_39077394 | 4.91 |
Cthrc1 |
collagen triple helix repeat containing 1 |
6 |
0.96 |
chr19_6498360_6498511 | 4.90 |
Nrxn2 |
neurexin II |
600 |
0.63 |
chr6_138422642_138422962 | 4.90 |
Lmo3 |
LIM domain only 3 |
115 |
0.74 |
chr12_80736804_80737027 | 4.89 |
Plekhd1 |
pleckstrin homology domain containing, family D (with coiled-coil domains) member 1 |
15183 |
0.11 |
chr16_73108327_73108499 | 4.89 |
4930500H12Rik |
RIKEN cDNA 4930500H12 gene |
9425 |
0.31 |
chr2_71545818_71546275 | 4.87 |
Dlx2 |
distal-less homeobox 2 |
96 |
0.96 |
chr19_10272860_10273195 | 4.86 |
Dagla |
diacylglycerol lipase, alpha |
16156 |
0.12 |
chr11_16591601_16591916 | 4.85 |
Gm12663 |
predicted gene 12663 |
44308 |
0.12 |
chr15_98180977_98181745 | 4.85 |
Olfr288 |
olfactory receptor 288 |
14084 |
0.1 |
chrX_143543266_143543620 | 4.84 |
Pak3 |
p21 (RAC1) activated kinase 3 |
24745 |
0.25 |
chr6_107529484_107530270 | 4.84 |
Lrrn1 |
leucine rich repeat protein 1, neuronal |
109 |
0.97 |
chr6_66398799_66398950 | 4.83 |
Gm44233 |
predicted gene, 44233 |
128 |
0.54 |
chr5_38881811_38882016 | 4.82 |
Clnk |
cytokine-dependent hematopoietic cell linker |
5101 |
0.3 |
chr2_178142310_178142985 | 4.81 |
Phactr3 |
phosphatase and actin regulator 3 |
714 |
0.75 |
chr5_125111202_125111425 | 4.81 |
Ncor2 |
nuclear receptor co-repressor 2 |
13587 |
0.18 |
chr12_52774500_52774651 | 4.79 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
21261 |
0.2 |
chr12_70347618_70348065 | 4.78 |
Trim9 |
tripartite motif-containing 9 |
227 |
0.66 |
chr13_25402125_25402276 | 4.77 |
F830002E08Rik |
RIKEN cDNA F830002E08 gene |
27927 |
0.21 |
chr8_17534538_17535388 | 4.76 |
Csmd1 |
CUB and Sushi multiple domains 1 |
318 |
0.95 |
chr1_3670747_3671221 | 4.76 |
Xkr4 |
X-linked Kx blood group related 4 |
514 |
0.76 |
chr7_89856490_89856666 | 4.76 |
Me3 |
malic enzyme 3, NADP(+)-dependent, mitochondrial |
27296 |
0.13 |
chr7_67414950_67415112 | 4.76 |
Gm33926 |
predicted gene, 33926 |
28902 |
0.15 |
chr5_111590604_111590813 | 4.71 |
Gm42489 |
predicted gene 42489 |
2908 |
0.28 |
chr10_90576386_90576809 | 4.70 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
15 |
0.99 |
chr16_78930671_78931556 | 4.69 |
Chodl |
chondrolectin |
164 |
0.97 |
chr1_50926777_50927001 | 4.69 |
Tmeff2 |
transmembrane protein with EGF-like and two follistatin-like domains 2 |
630 |
0.77 |
chr17_91092598_91092749 | 4.68 |
Nrxn1 |
neurexin I |
60 |
0.97 |
chr4_107834863_107835108 | 4.68 |
Lrp8 |
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
4000 |
0.13 |
chr9_45370099_45370254 | 4.68 |
Fxyd6 |
FXYD domain-containing ion transport regulator 6 |
9 |
0.97 |
chr6_55484275_55484600 | 4.68 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
24201 |
0.19 |
chr2_11100384_11100535 | 4.67 |
Gm13294 |
predicted gene 13294 |
197 |
0.91 |
chr10_70520578_70521126 | 4.66 |
Gm29783 |
predicted gene, 29783 |
15604 |
0.22 |
chr3_121588840_121589464 | 4.64 |
A730020M07Rik |
RIKEN cDNA A730020M07 gene |
54215 |
0.09 |
chr9_121549119_121549291 | 4.63 |
Gm47095 |
predicted gene, 47095 |
13054 |
0.14 |
chr4_25408601_25409020 | 4.62 |
Gm11894 |
predicted gene 11894 |
10539 |
0.22 |
chr2_136109089_136109240 | 4.60 |
Gm14218 |
predicted gene 14218 |
27842 |
0.19 |
chr1_9649236_9649536 | 4.60 |
Gm29520 |
predicted gene 29520 |
8804 |
0.14 |
chr7_62046082_62046717 | 4.59 |
Mir344f |
microRNA Mir344f |
151 |
0.94 |
chr8_12947304_12948554 | 4.59 |
Mcf2l |
mcf.2 transforming sequence-like |
10 |
0.49 |
chr6_54565112_54565286 | 4.57 |
Scrn1 |
secernin 1 |
1290 |
0.42 |
chr13_60045576_60045727 | 4.56 |
Gm48396 |
predicted gene, 48396 |
11974 |
0.16 |
chr4_141867396_141867802 | 4.56 |
Efhd2 |
EF hand domain containing 2 |
7321 |
0.11 |
chr5_76762265_76762416 | 4.56 |
C530008M17Rik |
RIKEN cDNA C530008M17 gene |
9972 |
0.2 |
chr12_33225108_33225317 | 4.56 |
Atxn7l1os1 |
ataxin 7-like 1, opposite strand 1 |
3642 |
0.27 |
chr12_111693687_111693960 | 4.56 |
Gm36635 |
predicted gene, 36635 |
9259 |
0.09 |
chr7_46096261_46096440 | 4.55 |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
2076 |
0.17 |
chr19_14340958_14341109 | 4.55 |
Tle4 |
transducin-like enhancer of split 4 |
254506 |
0.02 |
chr2_26485269_26485643 | 4.55 |
Notch1 |
notch 1 |
14958 |
0.09 |
chr4_102240847_102240998 | 4.54 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
13820 |
0.28 |
chr9_23378360_23378672 | 4.54 |
Bmper |
BMP-binding endothelial regulator |
4584 |
0.36 |
chr6_31835987_31836222 | 4.54 |
Gm13849 |
predicted gene 13849 |
49429 |
0.16 |
chr1_35869466_35870086 | 4.52 |
1110002O04Rik |
RIKEN cDNA 1110002O04 gene |
10069 |
0.21 |
chr9_72512325_72512476 | 4.52 |
Gm28010 |
predicted gene, 28010 |
1066 |
0.34 |
chrX_134404779_134404975 | 4.52 |
Drp2 |
dystrophin related protein 2 |
75 |
0.97 |
chr10_38554173_38554374 | 4.48 |
Gm22911 |
predicted gene, 22911 |
61208 |
0.14 |
chr5_28466748_28466936 | 4.47 |
9530036O11Rik |
RIKEN cDNA 9530036O11Rik |
142 |
0.8 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.5 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.9 | 8.6 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
2.8 | 11.3 | GO:0046959 | habituation(GO:0046959) |
2.1 | 6.4 | GO:0060166 | olfactory pit development(GO:0060166) |
2.1 | 6.4 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
2.1 | 6.4 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
2.1 | 6.2 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
2.1 | 6.2 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
2.0 | 13.9 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
2.0 | 6.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.9 | 7.8 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
1.9 | 9.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.7 | 5.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.5 | 10.5 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
1.5 | 4.5 | GO:0033058 | directional locomotion(GO:0033058) |
1.5 | 6.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.5 | 1.5 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.5 | 4.4 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
1.5 | 4.4 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
1.5 | 4.4 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.4 | 7.2 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
1.4 | 4.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.4 | 5.7 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
1.4 | 4.2 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
1.4 | 6.9 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.4 | 8.3 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
1.4 | 2.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.4 | 2.7 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
1.4 | 4.1 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.3 | 4.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
1.3 | 6.6 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.3 | 3.9 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.3 | 9.0 | GO:0071625 | vocalization behavior(GO:0071625) |
1.3 | 3.8 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
1.2 | 3.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.2 | 6.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.2 | 3.7 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.2 | 27.0 | GO:0001964 | startle response(GO:0001964) |
1.2 | 15.2 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.1 | 1.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.1 | 13.3 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
1.1 | 3.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.1 | 3.3 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
1.1 | 3.2 | GO:0021564 | vagus nerve development(GO:0021564) |
1.1 | 7.5 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
1.1 | 11.7 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
1.0 | 3.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.0 | 18.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.0 | 1.0 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.0 | 5.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.0 | 3.0 | GO:0060618 | nipple development(GO:0060618) |
1.0 | 4.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.0 | 4.9 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
1.0 | 2.9 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
1.0 | 2.9 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.9 | 2.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.9 | 2.8 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.9 | 4.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.9 | 2.8 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
0.9 | 2.8 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.9 | 0.9 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.9 | 1.8 | GO:0021586 | pons maturation(GO:0021586) |
0.9 | 7.2 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.9 | 0.9 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.9 | 3.5 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.9 | 3.5 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.9 | 2.6 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.9 | 2.6 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.9 | 1.7 | GO:0072034 | renal vesicle induction(GO:0072034) |
0.9 | 0.9 | GO:0009629 | response to gravity(GO:0009629) |
0.8 | 7.6 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.8 | 1.7 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.8 | 1.7 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.8 | 2.5 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.8 | 0.8 | GO:1903278 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
0.8 | 2.4 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.8 | 2.4 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.8 | 2.4 | GO:0072240 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.8 | 2.4 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.8 | 3.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.8 | 4.6 | GO:0048840 | otolith development(GO:0048840) |
0.8 | 3.8 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.8 | 2.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.8 | 4.6 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.8 | 1.5 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.7 | 0.7 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.7 | 2.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.7 | 2.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.7 | 5.0 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.7 | 3.5 | GO:0097264 | self proteolysis(GO:0097264) |
0.7 | 3.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.7 | 0.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.7 | 1.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.7 | 0.7 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.7 | 2.8 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.7 | 2.7 | GO:0061743 | motor learning(GO:0061743) |
0.7 | 6.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.7 | 0.7 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.7 | 4.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.7 | 1.3 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.7 | 2.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.7 | 3.4 | GO:0071420 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.7 | 2.0 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.7 | 2.7 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.7 | 2.0 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.7 | 2.0 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.7 | 5.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.7 | 0.7 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.7 | 2.6 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.7 | 2.0 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.6 | 1.3 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.6 | 1.9 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.6 | 2.6 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.6 | 3.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.6 | 10.2 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.6 | 1.9 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.6 | 13.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.6 | 0.6 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.6 | 3.7 | GO:0007614 | short-term memory(GO:0007614) |
0.6 | 1.2 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.6 | 4.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.6 | 1.8 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.6 | 1.2 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.6 | 1.8 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.6 | 7.3 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.6 | 3.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.6 | 0.6 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.6 | 1.8 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.6 | 1.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.6 | 1.8 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.6 | 32.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.6 | 4.6 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.6 | 1.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.6 | 6.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.6 | 2.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.6 | 1.7 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.6 | 1.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.6 | 6.8 | GO:0008038 | neuron recognition(GO:0008038) |
0.6 | 4.6 | GO:0015824 | proline transport(GO:0015824) |
0.6 | 2.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.6 | 6.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.6 | 6.1 | GO:0030828 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.5 | 1.6 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.5 | 4.8 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.5 | 1.1 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.5 | 0.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.5 | 3.2 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.5 | 1.6 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.5 | 37.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.5 | 1.5 | GO:0051182 | coenzyme transport(GO:0051182) |
0.5 | 0.5 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.5 | 1.5 | GO:0001927 | exocyst assembly(GO:0001927) |
0.5 | 2.5 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.5 | 1.5 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.5 | 2.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.5 | 2.5 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.5 | 1.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.5 | 2.4 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.5 | 2.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.5 | 2.9 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.5 | 0.5 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.5 | 1.0 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.5 | 3.3 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.5 | 1.9 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.5 | 1.9 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.5 | 62.6 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.5 | 1.4 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.5 | 2.4 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.5 | 0.9 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.5 | 0.9 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.5 | 0.9 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.5 | 0.9 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.5 | 1.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.5 | 1.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.5 | 2.7 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.5 | 1.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.5 | 5.9 | GO:0019228 | neuronal action potential(GO:0019228) |
0.5 | 0.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.5 | 1.8 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.4 | 0.9 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.4 | 1.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.4 | 1.3 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.4 | 0.9 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.4 | 0.8 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.4 | 1.3 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.4 | 0.4 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.4 | 1.3 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.4 | 1.3 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.4 | 2.9 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.4 | 2.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.4 | 1.6 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.4 | 0.8 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.4 | 0.8 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.4 | 1.2 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.4 | 5.2 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.4 | 9.6 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.4 | 0.8 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.4 | 1.6 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.4 | 1.6 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.4 | 0.8 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.4 | 1.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.4 | 0.4 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.4 | 1.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.4 | 0.8 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.4 | 0.4 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.4 | 1.5 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.4 | 3.4 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.4 | 3.4 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.4 | 0.8 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.4 | 2.3 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.4 | 4.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.4 | 2.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.4 | 0.7 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.4 | 1.1 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.4 | 1.8 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.4 | 0.7 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.4 | 2.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.4 | 0.7 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.4 | 0.4 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.4 | 1.1 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.4 | 1.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.4 | 1.4 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 1.0 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.3 | 2.4 | GO:0070141 | response to UV-A(GO:0070141) |
0.3 | 3.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 1.7 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 0.7 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.3 | 0.7 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.3 | 1.0 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.3 | 1.0 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.3 | 1.0 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.3 | 1.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.3 | 0.7 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.3 | 0.7 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.3 | 2.3 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.3 | 1.0 | GO:0061055 | myotome development(GO:0061055) |
0.3 | 0.7 | GO:0007412 | axon target recognition(GO:0007412) |
0.3 | 0.7 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.3 | 3.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 1.9 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.3 | 2.3 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.3 | 0.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.3 | 0.6 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 1.0 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.3 | 1.0 | GO:0032344 | regulation of aldosterone metabolic process(GO:0032344) |
0.3 | 0.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 0.9 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.3 | 1.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.3 | 0.9 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.3 | 1.6 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.3 | 0.3 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.3 | 0.6 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.3 | 0.6 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.3 | 1.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.3 | 1.8 | GO:0060004 | reflex(GO:0060004) |
0.3 | 0.6 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.3 | 0.9 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.3 | 1.8 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.3 | 1.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.3 | 0.9 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 2.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.3 | 0.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.3 | 4.4 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.3 | 1.2 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.3 | 2.3 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.3 | 0.6 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.3 | 0.3 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.3 | 1.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 0.9 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.3 | 1.4 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.3 | 0.6 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 1.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.3 | 0.3 | GO:0003211 | cardiac ventricle formation(GO:0003211) |
0.3 | 0.6 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.3 | 0.3 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.3 | 0.8 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.3 | 0.3 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.3 | 0.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 0.5 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.3 | 2.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.3 | 1.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 0.3 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.3 | 1.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.3 | 0.8 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.3 | 0.8 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 1.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 2.6 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.3 | 3.7 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.3 | 1.6 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.3 | 2.6 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.3 | 0.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 1.8 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 0.3 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.3 | 0.8 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.3 | 0.5 | GO:0035912 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.3 | 1.5 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.2 | 1.0 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
0.2 | 0.2 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.2 | 0.5 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.2 | 0.7 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 0.2 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.2 | 2.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 1.5 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.7 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.2 | 0.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.2 | 0.7 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.2 | 0.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 1.0 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 0.5 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.2 | 2.2 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.2 | 0.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.5 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.2 | 1.6 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.2 | 2.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 1.2 | GO:0060068 | vagina development(GO:0060068) |
0.2 | 1.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 4.6 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.2 | 0.9 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 0.7 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 0.7 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 0.2 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.2 | 0.9 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.2 | 1.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 0.2 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 0.2 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.2 | 2.9 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 0.7 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 0.2 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.2 | 0.2 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.2 | 0.9 | GO:0046689 | response to mercury ion(GO:0046689) |
0.2 | 1.3 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 0.2 | GO:0086011 | membrane repolarization during action potential(GO:0086011) |
0.2 | 1.8 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.2 | 0.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.2 | 0.7 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 2.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 0.4 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.2 | 0.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 0.6 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.2 | 0.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.2 | 1.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.2 | 0.6 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.2 | 0.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.2 | 1.0 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.2 | 1.6 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 0.4 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.2 | 0.2 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 0.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 0.6 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.2 | 0.2 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 6.5 | GO:0046847 | filopodium assembly(GO:0046847) |
0.2 | 0.6 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 20.2 | GO:0016358 | dendrite development(GO:0016358) |
0.2 | 1.6 | GO:0031000 | response to caffeine(GO:0031000) |
0.2 | 1.2 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.2 | 1.8 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 0.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 0.8 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.2 | 6.9 | GO:0006813 | potassium ion transport(GO:0006813) |
0.2 | 0.4 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.2 | 1.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.6 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.2 | 0.6 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.2 | 9.2 | GO:0050808 | synapse organization(GO:0050808) |
0.2 | 3.9 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.2 | 0.4 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 0.6 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.4 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 0.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 0.6 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 3.3 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.2 | 0.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.2 | 0.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 0.2 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.2 | 1.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 2.0 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 0.5 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 0.2 | GO:0035483 | gastric emptying(GO:0035483) |
0.2 | 0.4 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.2 | 0.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 1.2 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.2 | 0.9 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.2 | 0.9 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 0.5 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 0.7 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 0.5 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.2 | 1.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.5 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.2 | 1.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.2 | 0.5 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 2.3 | GO:0051904 | pigment granule transport(GO:0051904) establishment of pigment granule localization(GO:0051905) |
0.2 | 0.3 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 0.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.3 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.2 | 0.5 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 0.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 0.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.2 | 0.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 1.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 0.3 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.2 | 0.5 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 1.9 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.2 | 1.5 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.2 | 0.2 | GO:0072277 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.2 | 0.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 2.0 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.2 | 0.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 0.2 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 1.0 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.7 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.4 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.1 | 0.4 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.3 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.1 | 2.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.7 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 1.8 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 1.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.4 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.1 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.1 | 0.9 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.1 | 0.1 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.1 | 0.1 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.1 | 0.1 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.3 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.1 | 0.3 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.1 | 0.8 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 1.4 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.1 | 1.3 | GO:0097484 | dendrite extension(GO:0097484) |
0.1 | 0.5 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 1.3 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.1 | 0.1 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) |
0.1 | 0.1 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 1.4 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 1.6 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 2.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 1.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.1 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.7 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 1.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 0.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.4 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.4 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.7 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.1 | 0.5 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.3 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 6.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 1.0 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.1 | 0.2 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.1 | 0.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.5 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 | 1.1 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 1.1 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.1 | 0.5 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.6 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) negative regulation of cartilage development(GO:0061037) |
0.1 | 0.3 | GO:0051875 | melanosome localization(GO:0032400) pigment granule localization(GO:0051875) |
0.1 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.4 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.1 | GO:0032762 | mast cell cytokine production(GO:0032762) |
0.1 | 0.3 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.1 | 0.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.3 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.1 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.1 | 0.9 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.4 | GO:0034239 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
0.1 | 0.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 1.1 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.1 | 0.3 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.5 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.8 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 0.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.4 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.3 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.7 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 1.0 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.1 | 0.2 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 1.0 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.7 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.1 | 0.3 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 0.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.5 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.5 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 0.2 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 0.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.8 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.7 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.2 | GO:0015867 | ATP transport(GO:0015867) |
0.1 | 0.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.3 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.3 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.1 | 0.2 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.1 | 0.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.2 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.1 | 0.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.2 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.8 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 0.1 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.1 | 0.2 | GO:0048021 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.1 | 1.5 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.1 | 0.8 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 2.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.1 | GO:0072679 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.1 | 0.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.1 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.2 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 0.1 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.4 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.7 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.1 | 0.3 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.1 | 0.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.1 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.1 | 0.1 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.1 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.1 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.1 | 2.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.1 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 0.3 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.2 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.1 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 0.5 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.1 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 | 0.3 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.1 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.1 | 0.1 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.1 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.1 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.3 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.5 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.1 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.4 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.2 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.1 | 0.1 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.1 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.1 | 0.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.2 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.1 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.1 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 0.1 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.1 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 1.1 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.2 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.1 | 0.3 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.1 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.1 | 0.2 | GO:0061083 | regulation of protein refolding(GO:0061083) |
0.1 | 0.2 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.1 | 0.4 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.2 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 1.7 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.4 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.1 | 0.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 0.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.2 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.1 | GO:0060026 | convergent extension(GO:0060026) |
0.1 | 0.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 1.8 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.2 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.0 | 0.1 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.0 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.0 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.0 | 0.1 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.0 | 0.1 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.0 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.0 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.0 | 0.2 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.0 | GO:0060459 | left lung development(GO:0060459) |
0.0 | 0.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.3 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.2 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.0 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.0 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.0 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.0 | 0.2 | GO:0045837 | negative regulation of membrane potential(GO:0045837) |
0.0 | 0.0 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.0 | 0.0 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.0 | 0.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.0 | 0.1 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.0 | 0.1 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 0.1 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.0 | 0.4 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.0 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.0 | 0.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.1 | GO:0090135 | actin filament branching(GO:0090135) |
0.0 | 0.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.0 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.1 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.0 | 0.0 | GO:0022605 | oogenesis stage(GO:0022605) |
0.0 | 0.0 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.0 | 0.1 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.2 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.1 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.0 | 0.0 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.0 | 0.2 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.0 | 0.0 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.2 | GO:0009584 | detection of visible light(GO:0009584) |
0.0 | 0.1 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.9 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.0 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.8 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.0 | 0.1 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.0 | 0.1 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.0 | 0.0 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.0 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.1 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.1 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.0 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.0 | 0.2 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.0 | 0.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.3 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.1 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.0 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.3 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.1 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
0.0 | 0.5 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.0 | 0.7 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.1 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.0 | 0.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.2 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.0 | 0.3 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.1 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.0 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.0 | 0.0 | GO:0002371 | dendritic cell cytokine production(GO:0002371) regulation of dendritic cell cytokine production(GO:0002730) |
0.0 | 0.0 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.0 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.0 | 0.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.1 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.0 | 0.0 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.1 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.0 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.0 | 0.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.0 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.0 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.0 | 0.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.0 | 0.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.0 | 0.0 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.0 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.0 | 0.1 | GO:0046471 | phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.2 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.0 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.0 | 0.0 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.0 | GO:0042938 | dipeptide transport(GO:0042938) |
0.0 | 0.0 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.0 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.0 | 0.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.0 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.0 | 0.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.0 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 8.4 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.7 | 5.2 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.7 | 8.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.5 | 1.5 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
1.2 | 1.2 | GO:0097513 | myosin II filament(GO:0097513) |
1.2 | 3.5 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.1 | 4.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.1 | 4.4 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.1 | 3.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.1 | 6.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
1.0 | 3.1 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
1.0 | 4.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.0 | 9.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.0 | 3.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.0 | 4.0 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.0 | 8.8 | GO:0005883 | neurofilament(GO:0005883) |
0.9 | 28.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.9 | 11.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.9 | 8.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.9 | 24.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.8 | 8.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.8 | 0.8 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.8 | 8.8 | GO:0043194 | axon initial segment(GO:0043194) |
0.8 | 2.4 | GO:0097441 | basilar dendrite(GO:0097441) |
0.7 | 41.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.7 | 1.4 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.7 | 2.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.7 | 2.0 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.7 | 2.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.6 | 3.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.6 | 6.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.6 | 5.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.6 | 1.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.6 | 10.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.6 | 6.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.6 | 1.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.6 | 1.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.5 | 0.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.5 | 1.0 | GO:0033010 | paranodal junction(GO:0033010) |
0.5 | 5.4 | GO:0030673 | axolemma(GO:0030673) |
0.5 | 1.0 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.5 | 0.9 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.5 | 8.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.5 | 15.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.5 | 0.9 | GO:0044393 | microspike(GO:0044393) |
0.4 | 1.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.4 | 0.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.4 | 1.2 | GO:0032280 | symmetric synapse(GO:0032280) |
0.4 | 3.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.4 | 59.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.4 | 1.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 2.0 | GO:0097433 | dense body(GO:0097433) |
0.4 | 3.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.4 | 0.7 | GO:0072534 | perineuronal net(GO:0072534) |
0.4 | 3.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.3 | 1.0 | GO:0043511 | inhibin complex(GO:0043511) |
0.3 | 0.9 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.3 | 0.9 | GO:0042585 | germinal vesicle(GO:0042585) |
0.3 | 8.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 7.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.3 | 0.9 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 2.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.3 | 1.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.3 | 1.1 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 0.3 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 0.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 1.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 0.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 2.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 3.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 2.7 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 4.0 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 2.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.3 | 4.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.3 | 9.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.3 | 1.3 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.3 | 1.3 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 1.7 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 0.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.7 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 3.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 1.8 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 0.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 1.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 28.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 1.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 10.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 3.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 1.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 5.5 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 0.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 1.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 1.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 0.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 2.8 | GO:0043205 | fibril(GO:0043205) |
0.2 | 2.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 1.5 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.2 | 0.2 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.2 | 0.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 0.2 | GO:0044298 | cell body membrane(GO:0044298) |
0.2 | 1.0 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 1.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 1.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 0.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 4.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 0.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 4.4 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.7 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 2.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.4 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 6.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 9.6 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 2.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.5 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 2.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.9 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 3.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 3.9 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.5 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.6 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.5 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 0.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.2 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 1.8 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 1.0 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 1.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.6 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 17.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 1.5 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 3.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.5 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 1.7 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 3.1 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.3 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.2 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 0.2 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.0 | 0.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.3 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.0 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 2.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.0 | 0.2 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.0 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.2 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.0 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.0 | GO:0061574 | ASAP complex(GO:0061574) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 13.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
2.6 | 7.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.6 | 10.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
2.4 | 7.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
2.2 | 6.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
2.2 | 8.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.2 | 6.5 | GO:0048030 | disaccharide binding(GO:0048030) |
2.1 | 8.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.1 | 6.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.9 | 3.7 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.7 | 8.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.7 | 5.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.7 | 10.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.6 | 7.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.2 | 5.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.2 | 7.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.1 | 5.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.0 | 8.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
1.0 | 1.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.0 | 7.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.0 | 2.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.0 | 2.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.0 | 30.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.0 | 10.5 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.9 | 1.8 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.9 | 5.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.9 | 2.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.9 | 3.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.9 | 4.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.9 | 2.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.8 | 3.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.8 | 3.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.8 | 4.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.8 | 2.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.8 | 3.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.8 | 4.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.8 | 2.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.8 | 3.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.7 | 2.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.7 | 4.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.7 | 2.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.7 | 2.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.7 | 3.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.7 | 2.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.7 | 3.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.7 | 0.7 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.6 | 14.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.6 | 1.9 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.6 | 2.6 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.6 | 1.9 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.6 | 3.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.6 | 6.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.6 | 4.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.6 | 4.2 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.6 | 2.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.6 | 1.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.6 | 4.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.6 | 9.4 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.6 | 2.9 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.6 | 4.7 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.6 | 15.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.6 | 2.8 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.6 | 7.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.5 | 6.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.5 | 3.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.5 | 2.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 10.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.5 | 3.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 2.0 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.5 | 2.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.5 | 1.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.5 | 3.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.5 | 7.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.5 | 2.4 | GO:0017040 | ceramidase activity(GO:0017040) |
0.5 | 0.9 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.4 | 3.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.4 | 1.7 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.4 | 2.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 1.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.4 | 3.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.4 | 1.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.4 | 10.9 | GO:0005272 | sodium channel activity(GO:0005272) |
0.4 | 1.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.4 | 1.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 1.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.4 | 0.4 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.4 | 1.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 1.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.4 | 1.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 7.9 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.4 | 2.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 0.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.3 | 6.0 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.3 | 1.0 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.3 | 1.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 1.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 7.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 0.3 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.3 | 0.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.3 | 0.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.3 | 4.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.3 | 1.2 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.3 | 7.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.3 | 0.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 1.8 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.3 | 5.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.3 | 0.9 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 3.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 8.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.3 | 0.9 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 1.4 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.3 | 1.7 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 0.3 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.3 | 2.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 0.8 | GO:0051373 | FATZ binding(GO:0051373) |
0.3 | 1.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 1.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.3 | 1.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 2.9 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.3 | 0.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.3 | 1.1 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.3 | 1.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.3 | 0.5 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 2.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 2.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 3.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 2.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 1.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 1.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 2.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.7 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.2 | 0.5 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 3.8 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 1.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 2.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 0.7 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 2.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 2.3 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.2 | 1.4 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.2 | 1.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 1.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.2 | 0.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 0.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 6.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 1.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 0.9 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 1.3 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 6.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 3.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 1.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 0.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 2.2 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 1.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 7.1 | GO:0005267 | potassium channel activity(GO:0005267) |
0.2 | 3.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.4 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.2 | 2.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 1.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 1.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 0.6 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 1.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 2.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 0.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 1.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 0.6 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.2 | 0.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 1.1 | GO:0010851 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.2 | 2.8 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 0.8 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.2 | 4.1 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 0.6 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 0.6 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 5.7 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 0.6 | GO:1904680 | peptide-transporting ATPase activity(GO:0015440) peptide transmembrane transporter activity(GO:1904680) |
0.2 | 0.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 1.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.7 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 0.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 3.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 1.7 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 3.1 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.2 | 1.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 1.7 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.2 | 0.7 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 0.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 0.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 13.8 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 0.5 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 0.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 1.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 0.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 0.6 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 2.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.5 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 14.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 7.8 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 1.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.6 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.4 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 1.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.9 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 1.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 3.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 1.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 1.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 4.8 | GO:0018722 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.1 | 1.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 2.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 1.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.9 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 4.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.5 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.1 | 0.4 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 3.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 1.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.5 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 1.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 3.8 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.5 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 0.3 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 1.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.6 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 1.0 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.2 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 0.4 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.1 | 0.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.6 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 4.0 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 1.0 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 3.3 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.1 | 0.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.1 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.1 | 0.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 1.0 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.4 | GO:0018856 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.3 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 1.3 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 2.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.3 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 0.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.2 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.8 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 1.0 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.1 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 0.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 1.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.2 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.1 | 0.2 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.1 | 0.2 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.1 | 0.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 4.0 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 0.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.2 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 0.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 2.1 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.2 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.1 | 0.7 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.0 | 10.4 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.0 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.2 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.2 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.0 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.1 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.0 | 0.7 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.4 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.5 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.3 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.0 | 0.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.1 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.0 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 0.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.2 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.0 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 1.2 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.2 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.1 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.1 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.0 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.2 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.0 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 10.0 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 2.4 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 1.6 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.2 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.1 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 18.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.6 | 16.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.6 | 9.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.6 | 1.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.5 | 5.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.5 | 1.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 5.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 5.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 6.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 3.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 8.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 8.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 0.8 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 9.4 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 2.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 2.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 6.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 2.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 4.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 3.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 22.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 1.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 6.9 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 2.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 1.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 4.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 2.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 21.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 2.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 1.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 5.2 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 5.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 1.9 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
1.7 | 18.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.0 | 4.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.0 | 15.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.0 | 11.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.8 | 9.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.8 | 34.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.8 | 2.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.7 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.7 | 16.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.6 | 6.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.6 | 1.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.6 | 8.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.6 | 24.0 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.6 | 5.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.5 | 4.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.5 | 6.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.5 | 1.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.5 | 6.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.5 | 4.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.5 | 11.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.5 | 3.6 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.4 | 4.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 5.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.4 | 3.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 7.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.4 | 1.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 1.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 3.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 0.6 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 3.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.3 | 2.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 3.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 5.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 6.9 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.2 | 4.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 2.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 1.5 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 2.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 2.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 0.6 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.2 | 3.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 1.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 1.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 2.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 4.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 2.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 1.3 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 1.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 2.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 3.0 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 1.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.1 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.1 | 1.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.1 | 2.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 2.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.5 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 0.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 0.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 1.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 3.5 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.4 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 0.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 1.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.9 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 6.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.6 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.0 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.6 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.1 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.0 | 0.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |